- What do you hope attendees will gain at your webinar?
A fuller understanding of the impact of COVID-19, including the strategic economic cost on Pharma and while some disruption of clinical trials was always inevitable, I would like attendees to finish the webinar with a deeper appreciation of why the disruption caused by the pandemic was worse than it needed to have been. Attendees will learn COVID-19 exposed the shortcomings of most technologies and processes currently used to conduct clinical trials and that this painful lesson cannot be wasted! There are real alternatives available today that can deliver much greater resilience and minimise future uncertainty. It is already well known that clinical trials are inefficient and too expensive. The webinar will also explain how this can be addressed as part of a much-needed modernisation. As many others have commented, clinical trials will never be the same again and however long this pandemic will last, it would be crazy not to sweep out the old and bring in the new. The future has arrived.
2. What discussions do you look forward to having with the attendees?
We consulted with many individuals and sponsors to gain an understanding of their perspective, which we will share during the webinar, but we are also keen to have attendee participation. We will be asking some questions of attendees, some thought provoking, and we will anonymously summarize and share responses received.
3. What do you enjoy most about your role?
As CEO I often quip, I am “jack of all trades and master of none”. Joking aside, I like the breadth and variety of my role. No day is ever the same and the challenges and opportunities change over time! I am passionate and care about what we do, within Cmed and our industry. We do make a difference, helping to improve and save lives, and I enjoy contributing.
4. How did you get into the industry?
My mother was a nurse and my father was in the Royal Navy. I have therefore had an interest in medicine and warships ever since I was a small boy! The loss of my older brother to cancer steered me in the direction of clinical science and clinical trials. After a BSc and a PhD, attracted by the thought of a company car (!) I started as a CRA at Astra Pharmaceuticals, and the rest is history.
5. Where is your favourite place in the world and why?
With the current lockdown I should probably say home…! Actually, it is small Spanish Island where I am lucky enough to own a villa overlooking a beautiful sandy bay with a turquoise coloured sea. I am not saying more than that as I don’t want to it to become too crowded! The people are friendly, have more time for each other and it seems a less hurried pace of life. Plus of course, it is by the sea.
Click Here for a link to the webinar: https://bit.ly/2BMof1h